Intramolecular cyclisation routes to cyclopenta[14,15]-19-norsteroids

Abstract

14-Allyl-3-methoxy-14β-estra-1,3,5(10),15-tetraen-17-one 1 undergoes competitive Wacker oxidation at C-2′ and C-3′ to give the 14β-formylethyl and 14β-acetonyl Δ¹⁵-17-ketones 2 and 3 respectively. Alkaline treatment of 3 results in efficient intramolecular Michael reaction, and chemoselective modification of the resultant pentacyclic diketone 6 gives rise to novel cyclopenta[14,15] analogues 11 and 12 of estradiol. Low-temperature reaction of 3 with lithium hexamethyldisilazide–cerium(III) chloride furnishes mainly the product of intramolecular aldol reaction, and hence, the derived 14β,17β-propanoestra-1,3,5(10),15-tetraene-3,17β-diol 21. Alternative routes to 11 and 12, via intramolecular reductive cyclisation of the 14β-formylethyl Δ¹⁵-17-ketone 2, are described.

References

1. J. R. Bull, C. Hoadley, P. G. Mountford and L. M. Steer, J. Chem. Soc., Perkin Trans. 1, 1997, 1179.
2. J. R. Bull, P. G. Mountford, G. Kirsch, G. Neef, A. Mueller-Fahrnow and R. Wiechert, Tetrahedron, 1994, 50, 6363.
3. Unpublished receptor binding and bioassay data, Institute of Medicinal Chemistry, Schering AG, Berlin.
4. G. M. Anstead, K. E. Carlson and J. A. Katzenellenbogen, Steroids, 1997, 62, 268.
5. A. M. Brzozowski, A. C. W. Pike, Z. Dauter, R. E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G. L. Greene, J.-A. Gustafsson and M. Carlquist, Nature, 1997, 389, 753.
6. J.-M. Wurtz, U. Egner, N. Heinrich, D. Moras and A. Mueller-Fahrnow, J. Med Chem., 1998, 41, 1803.
7. For recent reviews dealing with comparable intramolecular reductive cyclisations see: G. A. Molsnder and C. R. Harris, Chem. Rev., 1996, 96, 307; J. E. McMurry, Chem. Rev., 1989, 89, 1513.
8. For recent reviews on Wacker oxidation see: R. Tsuji, in Compre-hensive Organic Synthesis, eds. B. M. Trost and I. Fleming, Vol. 7, Pergamon, 1991, ch. 3.4; R. Tsuji, Palladium Reagents and Catalysts, Wiley, 1995, pp. 22–30.
9. For recent reports of neighbouring group participation during Wacker oxidation, see: J.-Y. Lai, X.-X. Shi and L.-X. Dai, J. Org. Chem., 1992, 57, 3485; H. Pellissier, P.-Y. Michellys and M. Santelli, Tetrahedron Lett., 1994, 35, 6481; S.-K. Kang, K.-Y. Jung, J.-U. Chung, E.-Y. Namkoong and T.-H. Kim, J. Org. Chem., 1995, 60, 4678.
10. J. R. Bull, M. A. Sefton and R. I. Thomson, S. Afr. J. Chem., 1990, 43, 42; J. R. Bull, C. Grundler and M. L. Niven, J. Chem. Soc., Chem. Commun., 1993, 271 and refs. cited.
11. S. A. Bourne, J. R. Bull and P. G. Mountford, unpublished results.
12. E. J. Corey and K. Shimoji, J. Am. Chem. Soc., 1983, 105, 1662.
13. H. M. R. HoVmann, A. M. El-Khawaga and H.-H. Oehlerking, Chem. Ber., 1991, 124, 2147 and refs. cited.
14. J. E. McMurry, T. Lectka and J. G. Rico, J. Org. Chem., 1989, 54, 3748.
15. Competitive receptor binding assays were conducted at the Institute of Medicinal Chemistry, Schering AG, Berlin, in accordance with standard protocols for competition with estradiol, described by K. Lubke, E. Schillinger and M. Topert, Angew. Chem., Int. Ed. Engl., 1976, 15, 741.